Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$266,424
+$6,749 QoQ
Shares Held
1,700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,192
of 1,603 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Houlihan Financial Resource Group, Ltd. holds $4,447,659 across 5 Drug Manufacturers - General names. NVS ranks #5 (6.0% of the industry book) .
All Filings in NVS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,424 | 1,700 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $259,675 | 1,700 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $234,379 | 1,700 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $206,238 | 1,850 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $253,044 | 2,200 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $234,212 | 2,200 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $212,806 | 2,200 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $222,134 | 2,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $224,092 | 2,200 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,916,389 | 78,450 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $202,400 | 2,200 | Shares | Sole | 2023-05-11 | |
| 2020-09-30 | $302,186 | 3,475 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $286,513 | 3,475 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||